Ikarian Capital »

Evolus shares owned by Ikarian Capital

Quarter-by-quarter ownership of Evolus (EOLS) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Evolus

Tip: Access up to 7 years of quarterly data

All positions including Evolus held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evolus by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $4.1M 373k 11.04
2024-09-30 $4.2M 258k 16.20
2022-06-30 $529k 46k 11.62

More positions owned by Ikarian Capital

Spdr Ser Tr S&p Biotech Put Option (XBI)
Tyson Foods Cl A Put Option (TSN)
Tarsus Pharmaceuticals (TARS)
Crinetics Pharmaceuticals In (CRNX)
Bridgebio Pharma Call Option (BBIO)
Scholar Rock Hldg Corp Call Option (SRRK)
Amgen Call Option (AMGN)
Insmed Com Par $.01 Call Option (INSM)
Blueprint Medicines (BPMC)
Avidity Biosciences Ord Put Option (RNA)
Sarepta Therapeutics Call Option (SRPT)
Forte Biosciences Com New (FBRX)
Pilgrim's Pride Corporation Put Option (PPC)
Neumora Therapeutics Put Option (NMRA)
Miragen Therapeutics Call Option (VRDN)

View all positions for Ikarian Capital

Top funds holding Evolus

Perceptive Advisors
Tang Capital Management
BlackRock
Vanguard Group
Nantahala Capital Management
Caligan Partners
State Street Corporation
Millennium Management
Boothbay Fund Management
Stonepine Capital Management
Geode Capital Management
Soros Fund Management
UBS Group
Schroder Investment Management Group
Rice Hall James & Associates

View all funds holding Evolus